NL-OMON21122已完成不适用
Randomized induction and post induction therapy in older patients (>= 61 yrs of age) with acute myelocytic leukemia (AML) and refractory anemia with excess of blasts (RAEB, RAEB-t).
Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON)P/a HOVON Data CenterErasmus MC - DanielPostbus 5201NL-3008 AE RotterdamTel: 010 4391568Fax: 010 4391028e-mail: hdc@erasmusmc.nl0 个研究点目标入组 800 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 800
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Age 61 years or more;
- •2. Subjects with a cytopathologically
排除标准
- •1. Previous induction treatment for AML/MDS;
- •2. Prior chemotherapy within 6 months of study entry;
研究者
相似试验
已完成
3 期
Randomised induction and post induction therapy in older patients (greater than or equal to 61 years of age) with Acute Myelocytic Leukaemia (AML) and Refractory Anaemia with Excess of Blasts (RAEB, RAEB-t)CancerISRCTN77039377Dutch Haemato-Oncology Association (Stichting Hemato-Oncologie Volwassenen Nederland) (HOVON) (Netherlands)800
进行中（未招募）
不适用
Randomised induction and post induction therapy in older patients (>=61 years of age) with acute myeloid leukaemia (AML) and refractory anaemia with excess blasts (RAEB, RAEB-t) - HOVON 43Acute Myeloid Leukaemia (AML)Refractory Anaemia with Excesss Blasts (RAEB)EUCTR2004-001918-13-GBniversity of Wales College of Medicine800
已完成
不适用
Randomised induction and post-induction therapy in adult patients (less than or equal to 60 years of age) with acute myelocytic leukaemia (AML) or refractory anaemia with excess of blasts (RAEB, RAEB-t) with IPSS score greater than or equal to 1.5Acute myeloid leukaemia (AML)Myeloid leukaemiaCancerISRCTN38648181Dutch Haemato-Oncology Association (Stichting Hemato-Oncologie Volwassenen Nederland) (HOVON) (Netherlands)800
已完成
不适用
Randomized induction and post induction therapy in adult patients (= 1.5.Acute myelocytic leukemia, RAEB, RAEB-t.NL-OMON25506Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON)P/a HOVON Data CenterErasmus MC - Daniel den HoedPostbus 52013008 AE RotterdamTel: 010 4391568Fax: 010 4391028e-mail: hdc@erasmusmc.nl800
已完成
不适用
A randomized phase III study comparing induction chemotherapy to daily low dose Cisplatin both combined with high dose radiotherapy in patients with inoperable non-small cell lung cancer stage I, II and III.NL-OMON22854/A100